Exempt Chemical Preparations Under the Controlled Substances Act

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-372]

Exempt Chemical Preparations Under the Controlled Substances Act

AGENCY:

Drug Enforcement Administration (DEA), Department of Justice.

ACTION:

Order with opportunity for comment.

SUMMARY:

The applications for exempt chemical preparations received by DEA between July 1, 2012, and March 31, 2013, as listed below, were accepted for filing and have been approved or denied as indicated.

DATES:

Electronic comments must be submitted and written comments must be postmarked on or before September 3, 2013. The electronic Federal Docket Management System will not accept comments after midnight Eastern Time on the last day of the comment period.

ADDRESSES:

To ensure proper handling of comments, please reference “Docket No. DEA-372” on all electronic and written correspondence. DEA encourages that all comments be submitted electronically through

http://www.regulations.gov

using the electronic comment form provided on that site. An electronic copy of this document is also available at

http://www.regulations.gov

for easy reference. Paper comments that duplicate the electronic submission are not necessary as all comments submitted to

www.regulations.gov

will be posted for public review and are part of the official docket record. Written comments submitted via regular or express mail should be sent to the Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODL, 8701 Morrissette Drive, Springfield, Virginia 22152.

FOR FURTHER INFORMATION CONTACT:

John W. Partridge, Executive Assistant, Office of Diversion Control, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 307-7165.

SUPPLEMENTARY INFORMATION:

Posting of Public Comments

Please note that all comments received are considered part of the public record and made available for public inspection online at

http://www.regulations.gov

and in the DEA's public docket. Such information includes personal identifying information (such as your name, address, etc.) voluntarily submitted by the commenter.

If you want to submit personal identifying information (such as your name, address, etc.) as part of your comment, but do not want it to be posted online or made available in the public docket, you must include the phrase “PERSONAL IDENTIFYING INFORMATION” in the first paragraph of your comment. You must also place all the personal identifying information you do not want posted online or made available in the public docket in the first paragraph of your comment and identify what information you want redacted.

If you want to submit confidential business information as part of your comment, but do not want it to be posted online or made available in the public docket, you must include the phrase “CONFIDENTIAL BUSINESS INFORMATION” in the first paragraph of your comment. You must also prominently identify confidential business information to be redacted within the comment. If a comment has so much confidential business information that it cannot be effectively redacted, all or part of that comment may not be posted online or made available in the public docket.

Personal identifying information and confidential business information identified and located as set forth above will be redacted, and the comment, in redacted form, will be posted online and placed in DEA's public docket file. Please note that the Freedom of Information Act applies to all comments received. If you wish to inspect the agency's public docket file in person by appointment, please see the

FOR FURTHER INFORMATION CONTACT

paragraph.

Legal Authority

DEA implements and enforces Titles II and III of the Comprehensive Drug Abuse Prevention and Control Act of 1970, often referred to as the Controlled Substances Act and the Controlled Substances Import and Export Act (codified at Title 21, Chapter 13 of the U.S.C.), as amended (CSA). DEA drafts and publishes the implementing regulations for these statutes in Title 21 of the Code of Federal Regulations (CFR), parts 1300 to 1321. The CSA and its implementing regulations are designed to prevent, detect, and eliminate the diversion of controlled substances and listed chemicals into the illicit market while providing for a sufficient supply of controlled substances and listed chemicals for legitimate medical, scientific, research, and industrial purposes. Controlled substances have the potential for abuse and dependence and are controlled to protect the public health and safety.

Section 201 of the CSA (21 U.S.C. 811) authorizes the Attorney General, by regulation, to exempt from certain provisions of the CSA certain compounds, mixtures, or preparations containing a controlled substance, if he finds that such compounds, mixtures, or preparations meet the requirements detailed in 21 U.S.C. 811(g)(3)(B).

1

DEA regulations at 21 CFR 1308.23 and 1308.24 further detail the criteria by which the DEA Deputy Assistant Administrator may exempt a chemical preparation or mixture from the application of certain provisions of the CSA. The Deputy Assistant Administrator may, pursuant to 21 CFR 1308.23(f), modify or revoke the criteria by which exemptions are granted and modify the scope of exemptions at any time.

1

This authority has been delegated from the Attorney General to the Administrator of the DEA by 28 CFR 0.100 and subsequently redelegated to the Deputy Assistant Administrator pursuant to the Appendix to Subpart R of 28 CFR 0.104.

Exempt Chemical Preparation Applications Submitted Between July 1, 2012, and March 31, 2013

The Deputy Assistant Administrator received applications between July 1, 2012, and March 31, 2013, requesting exempt chemical preparation status pursuant to 21 CFR 1308.23. Pursuant to the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23, the Deputy Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart I below is intended for laboratory, industrial, educational, or special research purposes and not for general administration to a human being or other animal and either: (1) Contains no narcotic controlled substance and is packaged in such a form or concentration that the packaged quantity does not present any significant potential for abuse; or (2) contains either a narcotic or non-narcotic controlled substance and one or more adulterating or denaturing agents in such a manner, combination, quantity, proportion, or concentration that the preparation or mixture does not present any potential for abuse; if the preparation or mixture contains a narcotic controlled substance, it must be formulated in such a manner that it incorporates methods of denaturing or other means so that the preparation or mixture is not liable to be abused or have ill effects if abused, and so that the narcotic substance cannot in practice be removed.

Accordingly, pursuant to 21 U.S.C. 811(g)(3)(B), 21 CFR 1308.23, and 21 CFR 1308.24, the Deputy Assistant Administrator has determined that each of the chemical preparations or mixtures generally described in Chart I below and specifically described in the application materials received by DEA, are exempt, to the extent described in 21 CFR 1308.24, from application of sections 302, 303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 (21 U.S.C. 822-823, 825-829, and 952-954) of the CSA, and 21 CFR 1301.74, as of the date listed below that was provided in the approval letters to the individual requesters.

Chart I

Supplier

Product name

Form

Application date

AccuStandard, Inc

APP-9-086, a,a-Dimethylphenethylamine

Amber ampule: 1 mL

1/28/2013

AccuStandard, Inc

APP-9-086-20X, a,a-Dimethylphenethylamine

Amber ampule: 1 mL

1/28/2013

AccuStandard, Inc

AS-E1179, Chloral hydrate

Amber ampule: 1 mL

1/28/2013

AccuStandard, Inc

CLP-HC-X1, Composite Mix #3A

Amber ampule: 1 mL

1/28/2013

AccuStandard, Inc

M-551.1B, Disinfectant by-products

Amber ampule: 1 mL

1/28/2013

AccuStandard, Inc

M-551B, Disinfectant by-products

Amber ampule: 1 mL

1/28/2013

AccuStandard, Inc

M-551B-2, Chloral hydrate

Amber ampule: 1 mL

1/28/2013

AccuStandard, Inc

M-8015B/5031-21, Paraldehyde

Amber ampule: 1 mL

1/28/2013

AccuStandard, Inc

M-8206B-05, Additional VOC's by Method 8206B

Amber ampule: 1 mL

1/28/2013

AccuStandard, Inc

M-8270-02, Semi-Volatile by Capillary Column GC/MS Mix 2

Amber ampule: 1 mL

1/28/2013

AccuStandard, Inc

M-8270-04-ASL, Method 8270B—Base/Neutrals Mix

Amber ampule: 1 mL

1/28/2013

AccuStandard, Inc

M-8270-23-R1, Method 8270 Semi-Volatile Additions

Amber ampule: 1 mL

1/28/2013

AccuStandard, Inc

M-E-1179-M, Chloral hydrate

Amber ampule: 1 mL

1/28/2013

Agilent Technologies

Veterinary Drugs Checkout Mix

Amber ampule: 1 mL

8/3/2012

Agilent Technologies

Veterinary Drugs Comprehensive Mix—Submix 6

Amber ampule: 1 mL

8/3/2012

Agilent Technologies

Forensic Toxicology Comprehensive Mix—Submix 3

Amber ampule: 1 mL

8/3/2012

Agilent Technologies

Forensic Toxicology Comprehensive Mix—Submix 5

Amber ampule: 1 mL

8/3/2012

Agilent Technologies

Forensic Toxicology Comprehensive Mix—Submix 2

Amber ampule: 1 mL

8/3/2012

Agilent Technologies

Forensic Toxicology Checkout Mix

Amber ampule: 1 mL

8/3/2012

Agilent Technologies

Forensic Toxicology Comprehensive Mix—Submix 1

Amber ampule: 1 mL

12/6/2012

Alltech Associates, Inc

2C-T-2 Quik Check, 1.0 mg/mL

Glass ampule: 1 mL

9/26/2012

Alltech Associates, Inc

5-MeO-DMT Quick Check, 1.0 mg/mL

Glass ampule: 1 mL

9/26/2012

Alltech Associates, Inc

Carisoprodol Quik Check, 1.0 mg/mL

Glass ampule: 1 mL

9/26/2012

American Proficiency Institute

American Proficiency Institute SHBG/Testosterone

Amber bottle: 7 mL

12/5/2012

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Oral Fluid, OF23

Glass vials: 1 ml-200 mL

8/14/2012

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Urine, SD17

Glass vials: 1 ml-200 mL

8/14/2012

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Urine, MC176

Glass vials: 1 ml-200 mL

9/27/2012

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Urine, MC179

Glass vials: 1 ml-200 mL

10/23/2012

Biochemical Diagnostics, Inc

Salivabuse Custom Liquid Control Oral Fluid, OF25

Glass vials: 1 ml-200 mL

10/23/2012

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Urine, MC177

Glass vials: 1 ml-200 mL

11/5/2012

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Urine, MC178

Glass vials: 1 ml-200 mL

1/24/2013

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Oral Fluid, OF24

Glass vials: 1 ml-200 mL

1/24/2013

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Urine, MC181

Glass vials: 1 ml-200 mL

1/29/2013

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Urine, MC183

Glass vials: 1 ml-200 mL

3/12/2013

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Urine, MC184

Glass vials: 1 ml-200 mL

3/12/2013

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Urine, MC180

Glass vials: 1 ml-200 mL

3/14/2013

Bio-Rad Laboratories

Liquichek Immunoassay Plus Control Trilevel MiniPak

Box: 3 vials, 2.5 mL each

11/14/2012

Bio-Rad Laboratories

Liquichek Immunoassay Plus Control Level 1,2 and 3, Trilevel

Box: 12 vials, 5 mL each

11/21/2012

Bio-Rad Laboratories

Liquid Assayed Multiqual Premium, Levels 1-3

Box: 6 vials, 5 mL each

11/21/2012

Bio-Rad Laboratories

Liquid Assayed Multiqual Premium, Trilevel Minipak

Box: 3 vials, 5 mL each

11/21/2012

Bio-Rad Laboratories

Lyphocheck Urine Toxicology Control MiniPak, Cat. No. 470X

Glass vial: 25 mL

1/11/2013

Bio-Rad Laboratories

Liquichek Immunoassay Plus Control Level 1

Glass vial: 2.5 mL, Box 12 vials

2/20/2013

Bio-Rad Laboratories

Liquichek Immunoassay Plus Control Level 2

Glass vial: 2.5 mL, Box 12 vials

2/20/2013

Bio-Rad Laboratories

Liquichek Immunoassay Plus Control Level 3

Glass vial: 2.5 mL, Box 12 vials

2/20/2013

Cerilliant Corporation

Benzodiazepine Mix (1 mg/mL)

Glass Ampule: 1 mL

7/2/2012

Cerilliant Corporation

Class C Mix Urinalysis Internal Standard Fortified Morphine

Glass Ampule: 1 mL

7/9/2012

Cerilliant Corporation

Spice Cannabinoid Mix 2 (0.1 mg/mL)

Amber ampule: 1 mL

9/26/2012

Cerilliant Corporation

Spice Cannabinoid Mix 3 (0.1 mg/mL)

Amber ampule: 1 mL

9/26/2012

Cerilliant Corporation

Retigabine (1 mg/mL)

Glass Ampule: 1 mL

11/7/2012

Cerilliant Corporation

±-Norpseudoephedrine-D3 HCl (0.1 mg/mL)

Glass Ampule: 1 mL

1/7/2013

Cerilliant Corporation

Amobarbital-D5 (0.1 mg/mL)

Glass Ampule: 1 mL

1/7/2013

Cerilliant Corporation

2,5-Dimethoxy-4-(n)-propylthiophenethylamine HCl (2C-T-7 HCl) (1 mg/mL)

Glass Ampule: 1 mL

1/7/2013

Cerilliant Corporation

Class B Mix Urinalysis Internal Standard-8 (0.002-0.2 mg/mL), Pregabalin-D6 (1.0 mg/mL), Codeine-6-beta-glucoronide (1.0 mg/mL), Desomorphine (1.0 mg/mL), Levorphanol-D3 (0.1 mg/mL)

Glass ampule: 1 ml

1/22/2013

Cerilliant Corporation

Zaleplon-D4 (0.1 mg/mL)

Glass Ampule: 1 mL

1/31/2013

Cerilliant Corporation

Retigabine-D4 (0.1 mg/mL)

Glass ampule: 1ml

3/22/2013

Cerilliant Corporation

Tilidine-D6 HCl (0.1 mg/mL)

Glass ampule: 1ml

3/22/2013

Cliniqa Corporation

TDM Control, Levels 1-3

Dropper bottle: 5 mL

12/4/2012

ElSohly Laboratories, Inc

ELI Oral Fluid Controls, THC (0.5-50 ng/mL)

Glass vial: 5 ml-4 L

10/22/2012

ElSohly Laboratories, Inc

ELI Oral Fluid Controls, Methamphetamine (2-200 ng/mL)

Glass vial: 5 ml-4 L

10/22/2012

ElSohly Laboratories, Inc

ELI Oral Fluid Controls, Amphetamine, Benzoylecgonine, Morphine, Phencyclidine (2-200 ng/mL)

Glass vial: 5 ml-4 L

10/22/2012

ElSohly Laboratories, Inc

ELI Oral Fluid Controls, Multidrug (THC, Benzoylecgonine, Amphetamine, Methamphetamine, Morphine, Codeine, 6-Acetylmorphine, & PCP) at 0.5-50 ng/mL

Glass vial: 5 ml-4 L

10/22/2012

ElSohly Laboratories, Inc

ELI Oral Fluid Calibrators, THC (0.5-50 ng/mL)

Glass vial: 5 ml-4 L

10/22/2012

ElSohly Laboratories, Inc

ELI Oral Fluid Calibrators, Methamphetamine (2-200 ng/mL)

Glass vial: 5 ml-4 L

10/22/2012

ElSohly Laboratories, Inc

ELI Oral Fluid Calibrators, Amphetamine, Benzoylecgonine, Morphine, Phencyclidine (2-200 ng/mL)

Glass vial: 5 ml-4 L

10/22/2012

ElSohly Laboratories, Inc

ELI Oral Fluid Calibrators, Multidrug (THC, Benzoylecgonine, Amphetamine, Methamphetamine, Morphine, Codeine, 6-Acetylmorphine, & PCP) at 0.5-200 ng/mL

Glass vial: 5 ml-4 L

10/22/2012

Environmental Resource Associates (ERA)

USGS-BQS LS 4434 Mix 1

Glass Ampule: 2 mL

8/9/2012

Environmental Resource Associates (ERA)

USGS-BQS LS 4434 Mix 2

Glass Ampule: 2 mL

8/9/2012

Immunalysis Corporation

Tapentadol Calibrator Level 1 (100 ng/mL)

Glass vial: 10 mL

12/11/2012

Immunalysis Corporation

Tapentadol Calibrator Level 2 (200 ng/mL)

Glass vial: 10 mL

12/11/2012

Immunalysis Corporation

Tapentadol Calibrator Level 3 (500 ng/mL)

Glass vial: 10 mL

12/11/2012

Immunalysis Corporation

Tapentadol Calibrator Level 4 (1,000 ng/mL)

Glass vial: 10 mL

12/11/2012

Immunalysis Corporation

Tapentadol Low Control (150 ng/mL)

Glass vial: 10 mL

12/11/2012

Immunalysis Corporation

Tapentadol High Control (250 ng/mL)

Glass vial: 10 mL

12/11/2012

LGC Limited

(S)-(+)-Amphetamine (Dextroamphetamine) 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-Amphetamine 0.1 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-Amphetamine 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-Amphetamine-D11 0.1 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-Amphetamine-D11 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-Amphetamine-D5 (D-label on ring) 0.1 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Methamphetamine ((S)-(+)-Methamphetamine) 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-Methamphetamine 0.1 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-Methamphetamine 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-Methamphetamine-D5 0.1 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-Methamphetamine-D5 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Methcathinone Hydrochloride 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

9/24/2012

LGC Limited

Methylphenidate Hydrochloride 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

9/24/2012

LGC Limited

Amobarbital 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Pentobarbital 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Pentobarbital-D5 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Pentobarbital-D5 0.1 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Secobarbital 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-MDA-D5 (rac-3,4-Methylenedioxyamphetamine-D5) 0.1 mg/mL Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-MDA-D5 (rac-3,4-Methylenedioxyamphetamine-D5) 1.0 mg/mL Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-MBDB HCl (rac-N-Methyl-1-(3,4-Methylenedioxyphenyl)-2-butanamine Hydrochloride) 1.0 mg/mL Methanol (as free base)

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-MBDB-D5 (rac-N-Methyl-1-(3,4-Methylenedioxyphenyl)-2-butanamine-D5) 0.1 mg/mL Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-MDEA-D5 (rac-3,4-Methylenedioxy-N-ethylamphetamine-D5) 0.1 mg/mL Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-MDEA-D5 (rac-3,4-Methylenedioxy-N-ethylamphetamine-D5) 1.0 mg/mL Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-MDEA-D6 (rac-3,4-Methylenedioxy-N-ethylamphetamine-D6) 0.1 mg/mL Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-MDMA-D5 (rac-3,4-Methylenedioxymethamphetamine-D5) 0.1 mg/mL Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-MDMA-D5 (rac-3,4-Methylenedioxymethamphetamine-D5) 1.0 mg/mL Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Phencyclidine (PCP) 1.0 mg/mL Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Phencyclidine-D5 (PCP-D5) 0.1 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Phencyclidine-D5 (PCP-D5) 1.0 mg/mL Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Codeine 0.1 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Codeine 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Codeine-D3 0.1 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Codeine-D3 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Codeine-D6 0.1 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Codeine-D6 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Isocodeine 0.1 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Norcodeine 0.01 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Norcodeine 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Codeine N-Oxide 0.01 mg/mL Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Oxycodone-D3 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Oxycodone-D6 0.1 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Oxycodone-D6 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Hydromorphone 1.0 mg/mL Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Norhydromorphone Hydrochloride 1.0 mg/mL Methanol (as free base)

Glass vial: 1 mL

9/24/2012

LGC Limited

Pethidine (Meperidine) 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Pethidine-D4 (Meperidine-D4) 0.1 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Pethidine-D4 (Meperidine-D4) 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Morphine 0.1 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Morphine 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Morphine 3-beta-D-Glucuronide 0.1 mg/mL in Methanol/Water (

1/1

)

Glass vial: 1 mL

9/24/2012

LGC Limited

Morphine 3-beta-D-Glucuronide 1.0 mg/mL in Methanol with 0.05 percent Sodium Hydroxide (w/v)

Glass vial: 1 mL

9/24/2012

LGC Limited

Morphine 6-beta-D-Glucuronide 0.1 mg/mL in Methanol/Water (

1/1

)

Glass vial: 1 mL

9/24/2012

LGC Limited

Morphine 6-beta-D-Glucuronide 1.0 mg/mL Water/Methanol (80/20)

Glass vial: 1 mL

9/24/2012

LGC Limited

Morphine-D3 0.1 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Morphine-D3 1.0 mg/mL in Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Morphine N-Oxide 0.01 mg/mL Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

Normorphine 1.0 mg/mL Methanol

Glass vial: 1 mL

9/24/2012

LGC Limited

rac-Amphetamine-D10 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Amphetamine-D5 (D-label on ring) 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Amphetamine-D5 (D-label on side chain) 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Amphetamine-D5 (D-label on side chain) 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Amphetamine-D6 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Amphetamine-D6 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Amphetamine-D8 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Amphetamine-D8 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Methamphetamine-D11 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Methamphetamine-D11 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Methamphetamine-D14 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Methamphetamine-D14 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Methamphetamine-D8 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Methamphetamine-D8 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Methamphetamine-D9 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Methamphetamine-D9 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

(+)-Norpseudoephedrine Hydrochloride (Cathine Hydrochloride) 0.1 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

(R)-(+)-Cathinone Hydrochloride 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

(S)-(-)-Cathinone Hydrochloride 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

(S)-(-)-Methcathinone Hydrochloride 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Phentermine 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Fenfluramine Hydrochloride 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Methylphenidate-D9 Hydrochloride 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Pipradrol Hydrochloride 0.1 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Pipradrol Hydrochloride 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

GHB Sodium Salt (Sodium Gammahydroxybutyrate) 1.0 mg/mL in Methanol (as free acid)

Glass vial: 1 mL

11/30/2012

LGC Limited

GHB-D6 Sodium Salt (Sodium Gammahydroxybutyrate-D6) 0.1 mg/mL in Methanol (as free acid)

Glass vial: 1 mL

11/30/2012

LGC Limited

GHB-D6 Sodium Salt (Sodium Gammahydroxybutyrate-D6) 1.0 mg/mL in Methanol (as free acid)

Glass vial: 1 mL

11/30/2012

LGC Limited

Hexobarbital 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Methohexital 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Methohexital-D5 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Phenobarbital 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Phenobarbital-D5 (D-label on ring) 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Phenobarbital-D5 (D-label on ring) 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Phenobarbital-D5 (D-label on side chain) 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Phenobarbital-D5 (D-label on side chain) 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Methaqualone 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Methaqualone-D7 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Clonazepam 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Clonazepam-D4 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Chlordiazepoxide 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Chlordiazepoxide-D5 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Bromazepam 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Bromazepam 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Clobazam 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Delorazepam 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Estazolam 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Estazolam-D5 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Flunitrazepam 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Flunitrazepam 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Flunitrazepam-D7 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Prazepam 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Prazepam-D5 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Diazepam 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Diazepam 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Diazepam-D5 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Diazepam-D5 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Flurazepam 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Flurazepam 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Lormetazepam 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Zaleplon 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Pregabalin 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Pregabalin-D6 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Zolpidem Tartrate 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Zolpidem-D6 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Zopiclone 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Zopiclone Oxide 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Zopiclone-D4 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Meprobamate 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Nitrazepam 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Nitrazepam 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Nitrazepam-D5 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Oxazepam 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Oxazepam-D5 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Oxazepam-D5 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Nordazepam (Nordiazepam) 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Nordazepam (Nordiazepam) 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Nordazepam-D5 (Nordiazepam-D5) 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Nordazepam-D5 (Nordiazepam-D5) 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Alprazolam 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Alprazolam-D5 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Alprazolam-D5 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Methyltestosterone (17alpha-Methyltestosterone) 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Midazolam 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Midazolam-D4 Maleate 0.1 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Lorazepam 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Lorazepam 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Lorazepam Acetate ((3RS)-7-Chloro-5-(2-chlorophenyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl Acetate) 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Lorazepam-D4 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Lorazepam-D4 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Tetrazepam 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Triazolam 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Triazolam-D4 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Temazepam 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Temazepam 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Temazepam-D5 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Temazepam-D5 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Androstanolone (5alpha-Dihydrotestosterone, Stanolone) 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Androstenedione (Androst-4-ene-3, 17-dione) 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Boldenone 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Fluoxymesterone 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Mesterolone 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Methandienone 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Nandrolone 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Norandrostenedione (19-Norandrost-4-ene-3,17-dione) 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Norethandrolone 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Stanozolol 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Stanozolol-D3 0.1 mg/mL in 1,2-Dimethoxyethane

Glass vial: 1 mL

11/30/2012

LGC Limited

Testosterone 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Testosterone Benzoate 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Testosterone Isocaproate 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Testosterone Propionate 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Trenbolone 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

RCS-4 (DD-001, (4-Methoxyphenyl)(1-pentylindol-3-yl)methanone) 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

JWH-081 ((4-Methoxynaphthalen-1-yl)(1-pentylindol-3-yl)methanone) 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

JWH-122 ((4-Methylnaphthalen-1-yl)(1-pentylindol-3-yl)methanone) 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

JWH-203 (2-(2-Chlorophenyl)-1-(1-pentylindol-3-yl)ethanone) 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Ketamine Hydrochloride 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Ketamine-D4 Hydrochloride 0.1 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Iso-LSD (Lysergic Acid Diethylamide) 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

LAMPA (Lysergic Acid N-Methyl-N-propylamide) 0.025 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

LSD (Lysergic Acid Diethylamide) 0.025 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

LSD-D3 (Lysergic Acid Diethylamide-D3) 0.025 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

PMA HCl (p-Methoxyamphetamine) 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-MDA (rac-3,4-Methylenedioxyamphetamine) 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-MDEA (rac-3,4-Methylenedioxy-N-ethylamphetamine) 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

1-Methylamino-1-(3,4-methylenedioxyphenyl)propane Hydrochloride 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-BDB HCl (rac-3,4-Methylenedioxyphenyl-2-butanamine Hydrochloride) 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-MDMA (rac-3,4-Methylenedioxymethamphetamine) 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Bufotenine 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Methylone Hydrochloride 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Methylone-D3 Hydrochloride 0.1 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole) 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Cocaine 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Cocaine-D3 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Cocaine-D3 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Norcocaine Hydrochloride 1.0 mg/mL in Acetonitrile (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Norcocaine-D3 Hydrochloride 0.1 mg/mL in Acetonitrile (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

O-Methylcodeine 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Buprenorphine 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Buprenorphine 3-beta-D-Glucuronide 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Buprenorphine-D4 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Dihydrocodeine Hydrochloride 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Dihydrocodeine-D6 Hydrochloride 0.1 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Noroxycodone Hydrochloride 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Noroxycodone-D3 Hydrochloride 0.1 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Oxycodone 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Oxycodone-D3 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Dihydromorphine 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Hydromorphone-D3 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Anhydroecgonine Hydrochloride 1.0 mg/mL in Acetonitrile (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Anhydroecgonine Methyl Ester 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Benzoylecgonine 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Benzoylecgonine-D3 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Benzoylecgonine-D3 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Benzoylecgonine-D8 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Benzoylecgonine-D8 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Cocaethylene (Benzoylethylecgonine) 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Cocaethylene-D3 (Benzoylethylecgonine-D3) 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Cocaethylene-D8 (Benzoylethylecgonine-D8) 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Ecgonine 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Ecgonine Ethyl Ester 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Ecgonine Hydrochloride 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Ecgonine Methyl Ester 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Ecgonine Methyl Ester 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Ecgonine-D3 Hydrochloride 0.1 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Ecgonine-D3 Methyl Ester 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Ethylmorphine 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Hydrocodone 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Hydrocodone-D3 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Hydrocodone-D6 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Norhydrocodone Hydrochloride 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Heroin (Diacetylmorphine) 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Heroin-D9 (Diacetylmorphine-D9) 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Heroin-D9 (Diacetylmorphine-D9) 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Methadone 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Methadone 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Methadone-D3 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Methadone-D3 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Methadone-D9 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Methadone-D9 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Dextropropoxyphene 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Dextropropoxyphene 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Propoxyphene-D11 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Propoxyphene-D11 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Propoxyphene-D5 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

rac-Propoxyphene-D5 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

6-Acetylmorphine 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

6-Acetylmorphine 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

6-Acetylmorphine-D3 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

6-Acetylmorphine-D3 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

6-Acetylmorphine-D6 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

6-Acetylmorphine-D6 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Acetylcodeine 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Acetylcodeine 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Nordihydromorphine Hydrochloride 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Oxymorphone 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Oxymorphone-D3 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Oxymorphone-D3 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Noroxymorphone Hydrochloride 0.1 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Noroxymorphone Hydrochloride 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Butorphanol Tartrate 1.0 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

Sufentanil Citrate 0.1 mg/mL in Methanol (as free base)

Glass vial: 1 mL

11/30/2012

LGC Limited

cis-Tilidine (Ethyl (1R,2RS)-2-(Dimethylamino)-1-phenylcyclohex-3-enecarboxylate) 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

Tilidine 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

Microgenics Corporation

Abbott TDM Multiconstituent Calibrator (CAL 1-6) Catalog Number: 5P04-01

Box: 7 vials; 5 mL each

7/2/2012

Microgenics Corporation

Thermo Scientific DRI Opiate Assay Catalog Number: 100014602

Vial: 18 mL, Box: 3 vials

1/30/2013

Microgenics Corporation

Thermo Scientific DRI Cannabinoid Assay Catalog Number: 10014665

Vial: 18 mL, Box: 3 vials

1/30/2013

Microgenics Corporation

Thermo Scientific Phencyclidine Assay Catalog Number: 10014673

Vial: 18 mL, Box: 3 vials

1/30/2013

Microgenics Corporation

Thermo Scientific Ecstacy Assay Catalog Number: 10014681

Vial: 18 mL, Box: 3 vials

1/30/2013

Microgenics Corporation

Thermo Scientific CEDIA Methamphetamine OFT Calibrator 1: Catalog Number 10016362

Vial: 5 mL; Box: 1 vial

2/11/2013

Microgenics Corporation

Thermo Scientific CEDIA Methamphetamine OFT Calibrator 2: Catalog Number 10063

Vial: 5 mL; Box: 1 vial

2/11/2013

Microgenics Corporation

Thermo Scientific CEDIA Methamphetamine OFT Calibrator 3: Catalog Number 10016364

Vial: 5 mL; Box: 1 vial

2/11/2013

Microgenics Corporation

Thermo Scientific CEDIA Methamphetamine OFT Control 1: Catalog Number 10017686

Vial: 10 mL; Box: 1 vial

2/11/2013

Microgenics Corporation

Thermo Scientific CEDIA Methamphetamine OFT Control 2: Catalog Number 10017687

Vial: 10 mL; Box: 1 vial

2/11/2013

Microgenics Corporation

Thermo Scientific CEDIA Methamphetamine OFT Control 3: Catalog Number 1007688

Vial: 10 mL; Box: 1 vial

2/11/2013

Microgenics Corporation

Thermo Scientific CEDIA Multi-Drug OFT Calibrator 1: Catalog Number 10016882

Vial: 10 mL; Box: 1 vial

2/11/2013

Microgenics Corporation

Thermo Scientific CEDIA Multi-Drug OFT Calibrator 2: Catalog Number 10016883

Vial: 10 mL; Box: 1 vial

2/11/2013

Microgenics Corporation

Thermo Scientific CEDIA Multi-Drug OFT Calibrator 3: Catalog Number 10016884

Vial: 10 mL; Box: 1 vial

2/11/2013

Microgenics Corporation

Thermo Scientific CEDIA Multi-Drug OFT Control 1: Catalog Number 10017711

Vial: 15 mL; Box: 1 vial

2/11/2013

Microgenics Corporation

Thermo Scientific CEDIA Multi-Drug OFT Control 2: Catalog Number 10017712

Vial: 15 mL; Box: 1 vial

2/11/2013

Microgenics Corporation

Thermo Scientific CEDIA Multi-Drug OFT Control 3: Catalog Number 10017713

Vial: 15 mL; Box: 1 vial

2/11/2013

Microgenics Corporation

Thermo Scientific CEDIA THC OFT Calibrator 1: Catalog Number 10016700

Vial: 5 mL; Box: 1 vial

2/11/2013

Microgenics Corporation

Thermo Scientific CEDIA THC OFT Calibrator 2: Catalog Number 10016701

Vial: 5 mL; Box: 1 vial

2/11/2013

Microgenics Corporation

Thermo Scientific CEDIA THC OFT Calibrator 3: Catalog Number 10016702

Vial: 5 mL; Box: 1 vial

2/11/2013

Microgenics Corporation

Thermo Scientific CEDIA THC OFT Control 1: Catalog Number 10017702

Vial: 10 mL; Box: 1 vial

2/11/2013

Microgenics Corporation

Thermo Scientific CEDIA THC OFT Control 2: Catalog Number 10017703

Vial: 10 mL; Box: 1 vial

2/11/2013

Microgenics Corporation

Thermo Scientific CEDIA THC OFT Control 3: Catalog Number 10017704

Vial: 10 mL; Box: 1 vial

2/11/2013

Ortho Clinical Diagnostics, Inc

VITROS Immunodiagnostics Products Testosterone Reagent Pack

Plastic chamber: 8.4 mL

9/28/2012

Ortho Clinical Diagnostics, Inc

VITROS Immunodiagnostics Products Estradiol Reagent Pack

Plastic chamber: 13.3 mL

9/28/2012

Ortho Clinical Diagnostics, Inc

VITROS Immunodiagnostics Products Testosterone Calibrators (1-3)

Box: 3 vials; 2 mL each

10/19/2012

Ortho Clinical Diagnostics, Inc

VITROS Immunodiagnostics Products Testosterone Controls (1-3)

Box: 9 vials; 1 mL each

10/19/2012

Ortho Clinical Diagnostics, Inc

VITROS Immunodiagnostics Products Testosterone Range Verifiers (Low and High)

Box: 4 vials; 1-1.5 mL each

10/19/2012

Restek

Custom Revised Appendix IX Mix #1

Glass vial: 1.3 mL

2/14/2013

Restek Corporation

Product and Reactor Samples Standard

Ampule: 2 mL

10/12/2012

Restek Corporation

8270 Supplemental Standard #1

Ampule: 2 mL

12/13/2012

Siemens Healthcare Diagnostics Inc

TTST Stock X (Bulk)

Stock container: 50 mL-1 L

7/26/2012

Siemens Healthcare Diagnostics Inc

VS TTST Cal Bulk Soln Level 1

Bulk container: 4 mL-100 L

7/26/2012

Siemens Healthcare Diagnostics Inc

VS TTST Cal Bulk Soln Level 2

Bulk container: 4 mL-100 L

7/26/2012

Siemens Healthcare Diagnostics Inc

VS TTST Cal Bulk Soln Level 3

Bulk container: 4 mL-100 L

7/26/2012

Siemens Healthcare Diagnostics Inc

VS TTST Cal Bulk Soln Level 4

Bulk container: 4 mL-100 L

7/26/2012

Siemens Healthcare Diagnostics Inc

VS TTST Cal Bulk Soln Level 5

Bulk container: 4 mL-100 L

7/26/2012

Siemens Healthcare Diagnostics Inc

VS TTST Cal Bulk Soln Level 6

Bulk container: 4 mL-100 L

7/26/2012

Siemens Healthcare Diagnostics Inc

Dimension Vista TTST CAL A

Vial: 1 mL

7/26/2012

Siemens Healthcare Diagnostics Inc

Dimension Vista TTST CAL B

Vial: 1 mL

7/26/2012

Siemens Healthcare Diagnostics Inc

Dimension Vista TTST CAL C

Vial: 1 mL

7/26/2012

Siemens Healthcare Diagnostics Inc

Dimension Vista TTST CAL D

Vial: 1 mL

7/26/2012

Siemens Healthcare Diagnostics Inc

Dimension Vista TTST CAL E

Vial: 1 mL

7/26/2012

Siemens Healthcare Diagnostics Inc

Dimension Vista TTST CAL F

Vial: 1 mL

7/26/2012

Siemens Healthcare Diagnostics Inc

Dimension Vista System TTST CAL

Box: 12 vials; 1 ml each

7/26/2012

Siemens Healthcare Diagnostics Inc

MP TTST Lvl 1 Bulk

Bulk container: 4 mL-20 L

7/26/2012

Siemens Healthcare Diagnostics Inc

MP TTST Lvl 2 Bulk

Bulk container: 4 mL-20 L

7/26/2012

Siemens Healthcare Diagnostics Inc

MP TTST Lvl 3 Bulk

Bulk container: 4 mL-20 L

7/26/2012

Siemens Healthcare Diagnostics Inc

MP TTST Lvl 4 Bulk

Bulk container: 4 mL-20 L

7/26/2012

Siemens Healthcare Diagnostics Inc

MP TTST Lvl 5 Bulk

Bulk container: 4 mL-20 L

7/26/2012

Siemens Healthcare Diagnostics Inc

MP TTST Lvl 6 Bulk

Bulk container: 4 mL-20 L

7/26/2012

Siemens Healthcare Diagnostics Inc

MP TTST CAL Lvl 1 FC

Vial: 1-5 mL

7/26/2012

Siemens Healthcare Diagnostics Inc

MP TTST CAL Lvl 2 FC

Vial: 1-5 mL

7/26/2012

Siemens Healthcare Diagnostics Inc

MP TTST CAL Lvl 3 FC

Vial: 1-5 mL

7/26/2012

Siemens Healthcare Diagnostics Inc

MP TTST CAL Lvl 4 FC

Vial: 1-5 mL

7/26/2012

Siemens Healthcare Diagnostics Inc

MP TTST CAL Lvl 5 FC

Vial: 1-5 mL

7/26/2012

Siemens Healthcare Diagnostics Inc

MP TTST CAL Lvl 6 FC

Vial: 1-5 mL

7/26/2012

Siemens Healthcare Diagnostics Inc

TTST Stock S (Bulk)

Stock container: 50 mL-1 L

7/26/2012

Siemens Healthcare Diagnostics Inc

TTST Stock T (Bulk)

Stock container: 50 mL-1 L

7/26/2012

Siemens Healthcare Diagnostics Inc

Estradiol Diluent

Plastic container: 0.5L-1.0L

11/14/2012

Siemens Healthcare Diagnostics Inc

Dimension Vista Drug 1 CAL Pilot, Level B

Plastic test tube: 15 mL

12/3/2012

Supelco, Inc

Titan C18 Batch Test 1 Mix

Glass ampule: 1 mL

2/28/2013

The Deputy Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart II below is not consistent with the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23. Accordingly, the Deputy Assistant Administrator has determined that the chemical preparations or mixtures generally described in Chart II below and specifically described in the application materials received by DEA, are not exempt from application of any part of the CSA or from application of any part of the CFR, with regard to the requested exemption pursuant to 21 CFR 1308.23, as of the date listed below that was provided in the determination letters to the individual requesters.

Chart II

Supplier

Product name

Form

Application

date

Agilent Technologies

Forensic Toxicology Comprehensive Mix-Submix 9A

Ampule: 1 mL

12/6/2012

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Urine, MC177

Glass vials: 1 ml-200 mL

10/11/2012

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Urine, MC178

Glass vials: 1 ml-200 mL

10/23/2012

Biochemical Diagnostics, Inc

Salivabuse Custom Liquid Control Oral Fluid, OF24

Glass vials: 1 ml-200 mL

10/23/2012

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Urine, MC180

Glass vials: 1 ml-200 mL

12/14/2012

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Urine, MC181

Glass vials: 1 ml-200 mL

12/14/2012

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Urine, MC182

Glass vials: 1 ml-2 L

1/22/2013

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Urine, MC180

Glass vials: 1 ml-200 mL

1/29/2013

Biochemical Diagnostics, Inc

Detectabuse Custom Liquid Control Urine, MC182

Glass vials: 1 ml-2 L

2/14/2013

Cerilliant Corporation

(-)-11-nor-9-Carboxy-delta9-THC (1 mg/mL)

Glass ampule: 5 mL

7/6/2012

Cerilliant Corporation

Cocaine HCl (10 mg/mL)

Glass Ampule: 1 mL

7/6/2012

Cerilliant Corporation

Lacosamide (10 mg/mL)

Glass Ampule: 1 mL

9/12/2012

Cliniqa Corporation

TDM Control, Levels 1-3 Bulk

Plastic Container: 500 L

12/4/2012

ElSohly Laboratories, Inc

ELI Oral Fluid Controls, THC (0.5-50 ng/mL)

Glass vial: 5 ml-4 L

8/9/2012

ElSohly Laboratories, Inc

ELI Oral Fluid Controls, Methamphetamine (2-200 ng/mL)

Glass vial: 5 ml-4 L

8/9/2012

ElSohly Laboratories, Inc

ELI Oral Fluid Controls, Amphetamine, Benzoylecgonine, Morphine, Phencyclidine (2-200 ng/mL)

Glass vial: 5 ml-4 L

8/9/2012

ElSohly Laboratories, Inc

ELI Oral Fluid Controls, Multidrug (selected from THC, Cocaine/Benzoylecgonine, Amphetamines, Opiates, & PCP at 0.5-50 ng/mL)

Glass vial: 5 ml-4 L

8/9/2012

ElSohly Laboratories, Inc

ELI Oral Fluid Calibrators, THC (0.5-50 ng/mL)

Glass vial: 5 ml-4 L

8/9/2012

ElSohly Laboratories, Inc

ELI Oral Fluid Calibrators, Methamphetamine (2-200 ng/mL)

Glass vial: 5 ml-4 L

8/9/2012

ElSohly Laboratories, Inc

ELI Oral Fluid Calibrators, Amphetamine, Benzoylecgonine, Morphine, Phencyclidine (2-200 ng/mL)

Glass vial: 5 ml-4 L

8/9/2012

ElSohly Laboratories, Inc

ELI Oral Fluid Calibrators, Multidrug (selected from THC, Cocaine/Benzoylecgonine, Amphetamines, Opiates, & PCP at 0.5-200 ng/mL)

Glass vial: 5 ml-4 L

8/9/2012

LGC Limited

LAMPA (Lysergic Acid N-Methyl-N-propylamide) 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

LSD (Lysergic Acid Diethylamide) 1.0 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

LSD-D3 (Lysergic Acid Diethylamide-D3) 0.1 mg/mL in Acetonitrile

Glass vial: 1 mL

11/30/2012

LGC Limited

(-)-Cannabidiol 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Cannabinol 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

(-)-delta9-THC (Dronabinol) 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

(-)-delta9-THC-D3 (Dronabinol-D3) 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

trans-11-Hydroxy-delta9-THC ((6aRS,10aRS)-11-Hydroxy-delta9-tetrahydrocannabinol) 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

trans-11-Hydroxy-delta9-THC ((6aRS,10aRS)-11-Hydroxy-delta9-tetrahydrocannabinol) 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

trans-11-Hydroxy-delta9-THC-D3 (trans-11-Hydroxy-delta9-tetrahydrocannabinol-D3) 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

trans-11-Nor-9-carboxy-delta9-THC 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

trans-11-Nor-9-carboxy-delta9-THC-D3 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

trans-11-Nor-9-carboxy-delta9-THC-D3 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Fentanyl 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Fentanyl 1.0 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

LGC Limited

Fentanyl-D5 0.1 mg/mL in Methanol

Glass vial: 1 mL

11/30/2012

Siemens Healthcare Diagnostics Inc

Dimension Vista Drug 1 CAL Bulk, Level B

Plastic container: 4-100 L

12/3/2012

Scope of Approval

The exemptions are applicable only to the precise preparation or mixture described in the application submitted to DEA in the form(s) listed in this order and only for those sections of the CSA and the CFR that are specifically identified. Pursuant to 21 CFR 1308.24(h), any change in the quantitative or qualitative composition of the preparation or mixture or change in the trade name or other designation of the preparation or mixture after the date of application requires a new application. Pursuant to 21 CFR 1308.24(g), DEA may prescribe requirements other than those set forth in 1308.24(b)-(e) on a case-by-case basis for materials exempted in bulk quantities. Accordingly, in order to limit opportunity for diversion from the larger bulk quantities, DEA has determined that each of the exempted bulk products listed in this order may only be used by the manufacturer and may not be distributed by the manufacturer for any purpose or transported to other facilities.

Additional exempt chemical preparation requests received between July 1, 2012, and March 31, 2013, and not otherwise referenced in this order may remain under consideration until DEA receives additional information required, pursuant to 21 CFR 1308.23(d), as detailed in separate correspondence to individual requesters. DEA's order on such requests will be communicated to the public in a future

Federal Register

publication.

DEA also notes that these exemptions are limited to exemption from only those sections of the CSA and the CFR that are specifically identified in 21 CFR

1308.24(a). All other requirements of the CSA and the CFR apply, including, but not limited to, registration as an importer as required by 21 U.S.C. 957.

Chemical Preparations Containing Newly Controlled Substances

The statutory authority for exempt chemical preparations is based on the control status of substances contained within a preparation, the intended administration of a preparation, and the packaged form of a preparation. DEA conducts a case-by-case analysis of each application for exemption to determine whether exemption of a preparation from certain provisions of the CSA is appropriate pursuant to the specified statutory and regulatory requirements.

Most exempt chemical preparations have remained effective until the holder of a specific exempt chemical preparation specifically requested that the exemption be terminated. The CSA allows for modifications to the controlled substances schedules to add, remove, or change the schedule of substances thus resulting in periodic modifications to the control status of various substances. 21 U.S.C. 811(a). Since the CSA was enacted in 1970, DEA has on several occasions added to, removed from, or modified the schedules of controlled substances in accordance with the CSA. Such changes may result in the non-compliance of exempt chemical preparations with current statutes or regulations if chemical preparations that have already obtained exempt status contain newly controlled substances. For example, although an exempt chemical preparation may continue to be packaged in the same manner as when it was approved, non-controlled substances in the preparation may become controlled, thus prompting the need for a new application for exemption of the chemical preparation to ensure continued compliance. Other preparations that previously contained no controlled substances may contain newly controlled substances and thus would require an application for exemption.

DEA reviews applications for chemical preparation exemptions based on the statutes and regulations that are in place at the time of the application, including the control status of substances included in the preparation. DEA must remain vigilant to ensure that exempt chemical preparations remain consistent with the standards set forth in the CSA and its implementing regulations. As such, DEA reminds the public that any chemical preparation, regardless of whether it was previously exempt, that contains a newly controlled substance will require a new application for exemption pursuant to 21 U.S.C. 811(g)(3)(B) and 21 CFR 1308.23-1308.24.

Review of Exemptions Pursuant to 21 U.S.C. 811(g)(3)

Based on inquiries received from industry, DEA is conducting a comprehensive review of the exempt chemical preparation regulations. DEA's regulations at 21 CFR 1308.24(a) state that approved chemical preparations are exempt from certain provisions of both Subchapter I and Subchapter II of the CSA: “The chemical preparations and mixtures approved pursuant to 1308.23 are exempt from application of sections 302, 303, 305, 306, 307, 308, 309, 1002, 1003 and 1004 of the Act (21 U.S.C. 822-823, 825-829, 952-954) and 1301.74 of this chapter, to the extent described in paragraphs (b) to (h) of this section.” Pursuant to its regulations, DEA has provided exemptions from the application of section 302, 303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 of the Act (21 U.S.C. 822-823, 825-829, 952-954) and 21 CFR 1301.74 since the implementation of the regulations in the early 1970s. Until DEA's analysis of the exemption regulations is complete, DEA will continue to review and provide exemptions to chemical preparations consistent with the implementing regulations, when warranted. DEA will publish a future notice regarding the outcome of DEA's review of its regulations with respect to the exemption of chemical preparations.

Opportunity for Comment

Pursuant to 21 CFR 1308.23, any interested person may submit written comments on or objections to any chemical preparation in this order that has been approved or denied as exempt. If any comments or objections raise significant issues regarding any finding of fact or conclusion of law upon which this order is based, the Deputy Assistant Administrator will immediately suspend the effectiveness of any applicable part of this order until he may reconsider the application in light of the comments and objections filed.

Approved Exempt Chemical Preparations Are Posted on DEA's Web Site

A list of all current exemptions, including those listed in this order, is available on DEA's Web site at

http://www.DEAdiversion.usdoj.gov/schedules/exempt/exempt_chemlist.pdf.

The dates of applications of all current exemptions are posted for easy reference.

Dated: June 17, 2013.

Joseph T. Rannazzisi,

Deputy Assistant Administrator.

[FR Doc. 2013-16010 Filed 7-2-13; 8:45 am]

BILLING CODE 4410-09-P